Modulation of the Disordered Conformational Ensembles of the p53 Transactivation Domain by Cancer-Associated Mutations

Intrinsically disordered proteins (IDPs) are frequently associated with human diseases such as cancers, and about one-fourth of disease-associated missense mutations have been mapped into predicted disordered regions. Understanding how these mutations affect the structure-function relationship of IDPs is a formidable task that requires detailed characterization of the disordered conformational ensembles. Implicit solvent coupled with enhanced sampling has been proposed to provide a balance between accuracy and efficiency necessary for systematic and comparative assessments of the effects of mutations as well as post-translational modifications on IDP structure and interaction. Here, we utilize a recently developed replica exchange with guided annealing enhanced sampling technique to calculate well-converged atomistic conformational ensembles of the intrinsically disordered transactivation domain (TAD) of tumor suppressor p53 and several cancer-associated mutants in implicit solvent. The simulations are critically assessed by quantitative comparisons with several types of experimental data that provide structural information on both secondary and tertiary levels. The results show that the calculated ensembles reproduce local structural features of wild-type p53-TAD and the effects of K24N mutation quantitatively. On the tertiary level, the simulated ensembles are overly compact, even though they appear to recapitulate the overall features of transient long-range contacts qualitatively. A key finding is that, while p53-TAD and its cancer mutants sample a similar set of conformational states, cancer mutants could introduce both local and long-range structural modulations to potentially perturb the balance of p53 binding to various regulatory proteins and further alter how this balance is regulated by multisite phosphorylation of p53-TAD. The current study clearly demonstrates the promise of atomistic simulations for detailed characterization of IDP conformations, and at the same time reveals important limitations in the current implicit solvent protein force field that must be sufficiently addressed for reliable description of long-range structural features of the disordered ensembles.

[1]  Charles L Brooks,et al.  Linking folding with aggregation in Alzheimer's β-amyloid peptides , 2007, Proceedings of the National Academy of Sciences.

[2]  G. Hong,et al.  Nucleic Acids Research , 2015, Nucleic Acids Research.

[3]  M. Olivier,et al.  Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.

[4]  Jianhan Chen.  Effective Approximation of Molecular Volume Using Atom-Centered Dielectric Functions in Generalized Born Models. , 2010, Journal of chemical theory and computation.

[5]  J. Bergh,et al.  The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  R J DUBOS,et al.  Health and disease. , 1960, JAMA.

[7]  Nicholas Lyle,et al.  Describing sequence-ensemble relationships for intrinsically disordered proteins. , 2013, The Biochemical journal.

[8]  D. Shortle,et al.  Characterization of long-range structure in the denatured state of staphylococcal nuclease. II. Distance restraints from paramagnetic relaxation and calculation of an ensemble of structures. , 1997, Journal of molecular biology.

[9]  Charles L Brooks,et al.  Implicit modeling of nonpolar solvation for simulating protein folding and conformational transitions. , 2008, Physical chemistry chemical physics : PCCP.

[10]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[11]  Peter E Wright,et al.  Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein. , 2010, Biochemistry.

[12]  Zigang Dong,et al.  Post-translational modification of p53 in tumorigenesis , 2004, Nature Reviews Cancer.

[13]  R. Pappu,et al.  The denatured state ensemble contains significant local and long-range structure under native conditions: analysis of the N-terminal domain of ribosomal protein L9. , 2013, Biochemistry.

[14]  C. Brooks,et al.  Peptide and protein folding and conformational equilibria: theoretical treatment of electrostatics and hydrogen bonding with implicit solvent models. , 2005, Advances in protein chemistry.

[15]  Weihong Zhang,et al.  Residual Structures, Conformational Fluctuations, and Electrostatic Interactions in the Synergistic Folding of Two Intrinsically Disordered Proteins , 2012, PLoS Comput. Biol..

[16]  Kengo Kinoshita,et al.  Prediction of disordered regions in proteins based on the meta approach , 2008, Bioinform..

[17]  H. Jane Dyson,et al.  Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2 , 2009, Proceedings of the National Academy of Sciences.

[18]  Alberto Inga,et al.  The Biological Impact of the Human Master Regulator p53 Can Be Altered by Mutations That Change the Spectrum and Expression of Its Target Genes , 2006, Molecular and Cellular Biology.

[19]  A. Kidera,et al.  Disorder-to-order transition of an intrinsically disordered region of sortase revealed by multiscale enhanced sampling. , 2012, Journal of the American Chemical Society.

[20]  G. Clore,et al.  Elucidating transient macromolecular interactions using paramagnetic relaxation enhancement. , 2007, Current opinion in structural biology.

[21]  A. Fersht,et al.  Structure–function–rescue: the diverse nature of common p53 cancer mutants , 2007, Oncogene.

[22]  Liming Ying,et al.  Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer , 2009, Proceedings of the National Academy of Sciences.

[23]  H. Dyson,et al.  Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP. , 2009, Biochemistry.

[24]  Timothy H. Click,et al.  Intrinsically Disordered Proteins in a Physics-Based World , 2010, International journal of molecular sciences.

[25]  A. Levine,et al.  Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.

[26]  Andreas Vitalis,et al.  ABSINTH: A new continuum solvation model for simulations of polypeptides in aqueous solutions , 2009, J. Comput. Chem..

[27]  U. Hansmann.  Parallel tempering algorithm for conformational studies of biological molecules , 1997, physics/9710041.

[28]  Debabani Ganguly,et al.  Structural interpretation of paramagnetic relaxation enhancement-derived distances for disordered protein states. , 2009, Journal of molecular biology.

[29]  A. Fersht,et al.  Long-Range Modulation of Chain Motions within the Intrinsically Disordered Transactivation Domain of Tumor Suppressor p53 , 2011, Journal of the American Chemical Society.

[30]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[31]  M Madan Babu,et al.  Intrinsically disordered proteins. , 2012, Molecular bioSystems.

[32]  A. Levine,et al.  The P53 pathway: what questions remain to be explored? , 2006, Cell Death and Differentiation.

[33]  G. Wagner,et al.  Utilization of site-directed spin labeling and high-resolution heteronuclear nuclear magnetic resonance for global fold determination of large proteins with limited nuclear overhauser effect data. , 2000, Biochemistry.

[34]  A. Børresen-Dale,et al.  TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes , 2007, Oncogene.

[35]  M. Kitayner,et al.  Structural basis of DNA recognition by p53 tetramers. , 2006, Molecular cell.

[36]  Pamela D Vise,et al.  Identifying long‐range structure in the intrinsically unstructured transactivation domain of p53 , 2007, Proteins.

[37]  W. Greenleaf,et al.  High-resolution, single-molecule measurements of biomolecular motion. , 2007, Annual review of biophysics and biomolecular structure.

[38]  Rohit V. Pappu,et al.  Experiments and simulations show how long-range contacts can form in expanded unfolded proteins with negligible secondary structure , 2013, Proceedings of the National Academy of Sciences.

[39]  Vladimir Vacic,et al.  Disease-Associated Mutations Disrupt Functionally Important Regions of Intrinsic Protein Disorder , 2012, PLoS Comput. Biol..

[40]  H. Dyson,et al.  Unfolded proteins and protein folding studied by NMR. , 2004, Chemical reviews.

[41]  Alexander D. MacKerell,et al.  Improved treatment of the protein backbone in empirical force fields. , 2004, Journal of the American Chemical Society.

[42]  R. Pappu,et al.  Conformations of intrinsically disordered proteins are influenced by linear sequence distributions of oppositely charged residues , 2013, Proceedings of the National Academy of Sciences.

[43]  P. Rouanet,et al.  Interest of investigating p53 status in breast cancer by four different methods. , 2002, Oncology reports.

[44]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[45]  Rohit V. Pappu,et al.  Hamiltonian Switch Metropolis Monte Carlo Simulations for Improved Conformational Sampling of Intrinsically Disordered Regions Tethered to Ordered Domains of Proteins , 2014, Journal of chemical theory and computation.

[46]  Robert B. Best,et al.  A Preformed Binding Interface in the Unbound Ensemble of an Intrinsically Disordered Protein: Evidence from Molecular Simulations , 2012, PLoS Comput. Biol..

[47]  Charles L. Brooks,et al.  Generalized born model with a simple smoothing function , 2003, J. Comput. Chem..

[48]  Debabani Ganguly,et al.  Atomistic details of the disordered states of KID and pKID. Implications in coupled binding and folding. , 2009, Journal of the American Chemical Society.

[49]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[50]  D. Eliezer,et al.  Biophysical characterization of intrinsically disordered proteins. , 2009, Current opinion in structural biology.

[51]  D. Livingston,et al.  Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300 , 2003, Science.

[52]  L. Iakoucheva,et al.  Intrinsic disorder in cell-signaling and cancer-associated proteins. , 2002, Journal of molecular biology.

[53]  Markus Zweckstetter,et al.  NMR: prediction of molecular alignment from structure using the PALES software , 2008, Nature Protocols.

[54]  M. Westphal,et al.  Comparative assessment of the functional p53 status in glioma cells. , 2005, Anticancer research.

[55]  Jianhan Chen,et al.  Intrinsically disordered p53 extreme C-terminus binds to S100B(betabeta) through "fly-casting". , 2009, Journal of the American Chemical Society.

[56]  Jianhan Chen,et al.  Efficiency of Adaptive Temperature-Based Replica Exchange for Sampling Large-Scale Protein Conformational Transitions. , 2013, Journal of chemical theory and computation.

[57]  Kyou-Hoon Han,et al.  Local Structural Elements in the Mostly Unstructured Transcriptional Activation Domain of Human p53* , 2000, The Journal of Biological Chemistry.

[58]  Jianhan Chen.  Intrinsically Disordered p53 Extreme C-Terminus Binds to S100B(ββ) through “Fly-Casting” , 2009 .

[59]  István Simon,et al.  Is there a biological cost of protein disorder? Analysis of cancer-associated mutations. , 2012, Molecular bioSystems.

[60]  Weihong Zhang,et al.  Accelerate Sampling in Atomistic Energy Landscapes Using Topology-Based Coarse-Grained Models. , 2014, Journal of chemical theory and computation.

[61]  Guillaume Bouvier,et al.  A convective replica‐exchange method for sampling new energy basins , 2013, J. Comput. Chem..

[62]  G. Zambetti,et al.  The p53 mutation “gradient effect” and its clinical implications , 2007, Journal of cellular physiology.

[63]  R. Shrestha,et al.  Modeling the accessible conformations of the intrinsically unstructured transactivation domain of p53 , 2008, Proteins.

[64]  P. Jeffrey,et al.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.

[65]  C. Brooks,et al.  Balancing solvation and intramolecular interactions: toward a consistent generalized Born force field. , 2006, Journal of the American Chemical Society.

[66]  M. Blackledge,et al.  Defining long-range order and local disorder in native alpha-synuclein using residual dipolar couplings. , 2005, Journal of the American Chemical Society.

[67]  Charles L Brooks,et al.  Exploring atomistic details of pH-dependent peptide folding , 2006, Proceedings of the National Academy of Sciences.

[68]  V. Vacic,et al.  Disease mutations in disordered regions--exception to the rule? , 2012, Molecular bioSystems.

[69]  Rahul Roy,et al.  A practical guide to single-molecule FRET , 2008, Nature Methods.

[70]  Jianhan Chen.  Towards the physical basis of how intrinsic disorder mediates protein function. , 2012, Archives of biochemistry and biophysics.

[71]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[72]  A. Fersht,et al.  Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain , 2008, Proceedings of the National Academy of Sciences.

[73]  Hongwei Wu,et al.  Impact of the K24N mutation on the transactivation domain of p53 and its binding to murine double‐minute clone 2 , 2013, Proteins.

[74]  Wei Gu,et al.  Modes of p53 Regulation , 2009, Cell.

[75]  Collin M. Stultz,et al.  Constructing ensembles for intrinsically disordered proteins. , 2011, Current opinion in structural biology.

[76]  Alexander D. MacKerell,et al.  Extending the treatment of backbone energetics in protein force fields: Limitations of gas‐phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations , 2004, J. Comput. Chem..

[77]  Christopher J. Oldfield,et al.  Intrinsically disordered proteins in human diseases: introducing the D2 concept. , 2008, Annual review of biophysics.

[78]  Peter E. Wright,et al.  Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation , 2010, Proceedings of the National Academy of Sciences.

[79]  Alexander D. MacKerell,et al.  Force field influence on the observation of π-helical protein structures in molecular dynamics simulations , 2003 .

[80]  Christopher J. Oldfield,et al.  Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling , 2005, Journal of molecular recognition : JMR.

[81]  Miron Livny,et al.  BioMagResBank , 2007, Nucleic Acids Res..

[82]  Charles L Brooks,et al.  Folding intermediate in the villin headpiece domain arises from disruption of a N-terminal hydrogen-bonded network. , 2007, Journal of the American Chemical Society.

[83]  Weihong Zhang,et al.  Replica exchange with guided annealing for accelerated sampling of disordered protein conformations , 2014, J. Comput. Chem..

[84]  P. May,et al.  Twenty years of p53 research: structural and functional aspects of the p53 protein , 1999, Oncogene.

[85]  H. Dyson,et al.  Intrinsically unstructured proteins and their functions , 2005, Nature Reviews Molecular Cell Biology.

[86]  Wei Gu,et al.  p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.

[87]  D. Shortle,et al.  Characterization of long-range structure in the denatured state of staphylococcal nuclease. I. Paramagnetic relaxation enhancement by nitroxide spin labels. , 1997, Journal of molecular biology.

[88]  Lila M. Gierasch,et al.  Sending Signals Dynamically , 2009, Science.

[89]  S. Kato,et al.  Understanding the function–structure and function–mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[90]  Toshiaki Hara,et al.  Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. , 2006, Molecular cell.

[91]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[92]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[93]  J. Forman-Kay,et al.  Atomic-level characterization of disordered protein ensembles. , 2007, Current opinion in structural biology.

[94]  W. Eaton,et al.  Protein folding studied by single-molecule FRET. , 2008, Current opinion in structural biology.

[95]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[96]  Michael Feig,et al.  MMTSB Tool Set: enhanced sampling and multiscale modeling methods for applications in structural biology. , 2004, Journal of molecular graphics & modelling.

[97]  A. Fersht,et al.  Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2 , 2009, Oncogene.

[98]  T. Uchida,et al.  p53 mutations and prognosis in bladder tumors. , 1995, The Journal of urology.

[99]  John E Straub,et al.  Generalized replica exchange method. , 2010, The Journal of chemical physics.